Long COVID Research, 2020–2024: A PubMed-Based Bibliometric Analysis
Healthcare,
Год журнала:
2025,
Номер
13(3), С. 298 - 298
Опубликована: Фев. 1, 2025
Long
COVID
is
a
SARS-CoV-2
infection-associated
chronic
condition
with
great
potential
to
impact
health
and
socioeconomic
outcomes.
The
research
efforts
face
the
challenges
related
long
have
resulted
in
substantial
amount
of
publications,
which
warrants
need
for
bibliometric
profiling.
This
large-scale
PubMed-based
analysis
more
than
390,000
COVID-19
publications.
overall
aim
was
update
profile
publications
comparison
rest
scientific
literature
through
December
2024.
estimated
proportion
relatively
low
(2.3%
all
publications),
although
cumulative
frequency
(n
=
8928)
continues
pose
challenge
proper
information
management.
Currently,
“treatment”
“mechanism”
appear
be
most
predominant
topics
literature.
Interestingly,
this
evaluation
revealed
distinctive
literature,
clear
preponderance
“case
report”
when
compared
other
also
identified
ranked
prolific
journals
production
COVID-related
study
may
improve
visibility
contribute
management
growing
knowledge
on
COVID.
Язык: Английский
Rapid and accurate detection of SARS-CoV-2 spike protein by aptamer conformation change based on a reusable aptasensor
Microchimica Acta,
Год журнала:
2025,
Номер
192(4)
Опубликована: Март 25, 2025
Язык: Английский
The erasure of infection-associated chronic conditions: Critical interpretive synthesis of literature on healthcare for long COVID and related conditions in Brazil
Global Public Health,
Год журнала:
2025,
Номер
20(1)
Опубликована: Апрель 21, 2025
Evidence
is
emerging
that
long
COVID
at
least
as
prevalent
in
the
Global
South
North,
but
literature
on
healthcare
its
infancy.
Brazil
seeing
significant
levels
of
debility
due
to
a
limited
national
evidence-base.
shares
symptomatology
and
appropriate
care
with
wider
category
infection-associated
chronic
conditions
(IACCs).
This
article
reviews
published
between
2000
2023
addressing
for
IACCs
Brazil,
interest
exploring
challenges
opportunities
SUS
(Brazil's
universal
health
system)
offer
healthcare.
We
find
collectively
are
subject
erasure
from
Brazilian
knowledge,
through
lack
expertise,
resource-limited
system
prioritising
urgent
care,
concentration
poor
marginalised
populations
decision-making
power.
A
nascent
intellectual
will
address
COVID,
tradition
social
participation
governance
present
potential
opportunities.
call
ignition
global
step-change
tackling
IACCs.
equity
requires
development
sharing
expertise
regarding
context-specific
features.
Язык: Английский
Pentoxifylline in COVID-19 and considerations for its research in long COVID
Inflammation Research,
Год журнала:
2024,
Номер
73(12), С. 2057 - 2068
Опубликована: Окт. 24, 2024
Pentoxifylline
(PTX)
affects
most
blood
components
and
the
vessels,
potentially
modulating
various
conditions.
Due
to
its
impact
on
markers
linked
COVID-19
severity,
research
has
explored
PTX
for
acute
COVID-19.
Following
widespread
administration
of
vaccinations,
there
been
a
notable
consistently
growing
increase
in
focusing
long
COVID.
Consequently,
our
examination
relevant
data
shall
additionally
be
contextualized
into
COVID
research.
Язык: Английский